We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Recall, 510(k) Guidances Continue ‘Risk-Averse’ Trend
FDA Recall, 510(k) Guidances Continue ‘Risk-Averse’ Trend
October 18, 2013
The FDA’s devices center continues to avoid taking risks in guidance documents and other activities, and one industry insider blames a “perfect storm” of conditions: a generally inexperienced review staff, criticism of the 510(k) program and aggressive performance goals set during user fee negotiations that were not coupled with performance standards.